Kala Bio (KALA) Return on Capital Employed [ROCE] (2017 - 2026)
Kala Bio's Return on Capital Employed [ROCE] came in at -211.73% for Q2 2026, down 54.31 percentage points from -157.42% a year earlier but up 112.37 percentage points from the prior quarter.
Kala Bio (KALA) Return on Capital Employed [ROCE] (2017 - 2026) Analysis & Trends
For FY2025, Kala Bio's Return on Capital Employed [ROCE] was -130.57%, down 24.83 percentage points from FY2024.
- Return on Capital Employed [ROCE] carries a five-year change of -72.51 percentage points (FY2020 to FY2025).
- Going back by year, Return on Capital Employed [ROCE] was -105.74% in FY2024 (-42.82 pp), -62.92% in FY2023 (+30.53 pp), -93.44% in FY2022 (-2.42 pp) and -91.02% in FY2021 (-32.96 pp).
- The five-year range for quarterly Return on Capital Employed [ROCE] is -324.10% (Q1 2026) to -63.35% (Q3 2021).
- Year-over-year, Return on Capital Employed [ROCE] has declined for three consecutive quarters, with an average year-over-year change of -81.36 percentage points over the last seven quarters.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q3 2023 (a gain of 186.96 percentage points), and the weakest in Q3 2022 (a drop of 198.91 percentage points).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Kala Bio | 5.81 Mn | 5.81 Mn | - | -211.73% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -211.73% |
| Mar 31, 2026 | -324.10% |
| Dec 31, 2025 | -265.29% |
| Jun 30, 2025 | -157.42% |
| Mar 31, 2025 | -137.48% |
| Dec 31, 2024 | -108.35% |
| Sep 30, 2024 | -121.10% |
| Jun 30, 2024 | -104.69% |
| Mar 31, 2024 | -93.66% |
| Dec 31, 2023 | -79.03% |
| Sep 30, 2023 | -75.31% |
| Jun 30, 2023 | -77.47% |
| Mar 31, 2023 | -90.21% |
| Dec 31, 2022 | -134.89% |
| Sep 30, 2022 | -262.26% |
| Jun 30, 2022 | -198.48% |
| Mar 31, 2022 | -143.24% |
| Dec 31, 2021 | -100.81% |
| Sep 30, 2021 | -63.35% |
| Jun 30, 2021 | -57.07% |
Kala Bio Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=KALA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "KALA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=KALA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();